Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production

Blood

Volumn 100, Issue 7, 2002, Pages 2330-2340

  Kim, Mee Rhan ^a,b   Manoukian, Raffi ^a   Yeh, Richard ^a   Silbiger, Scott M ^a   Danilenko, Dimitry M ^a   Scully, Sheila ^a   Sun, Jilin ^a   DeRose, Margaret L ^a   Stolina, Marina ^a   Chang, David ^a   Van Gwyneth, Y ^a   Clarkin, Kristie ^a   Nguyen, Hung Q ^a   Yu, Yan Bin ^a   Jing, Shuqian ^a   Senaldi, Giorgio ^a   Elliott, Gary ^a   Medlock, Eugene S ^a  

^a AMGEN INC   (United States)

^b MS 35 1 B   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CD19 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR3; COMPLEMENTARY DNA; CYTOKINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8;

ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; BLOOD; BONE MARROW; CONTROLLED STUDY; EOSINOPHILIA; GENE OVEREXPRESSION; HEMATOPOIESIS; INFLAMMATION; LYMPH NODE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPLEEN; TRANSGENIC MOUSE;

EID: 0036785392     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-01-0012     Document Type: Article

References (59)

1. Chabaud M, Fossiez F, Taupin J-L, Miossec P. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J Immunol. 1998;161:409-414.
2. Matusevicius D, Kivisakk P, He B, et al. Interleukin-17 mRNA expression in blood and CSF mononudear cells is augmented in multiple sclerosis. Mult Scler. 1999;5:101-104.
3. Chabaud M, Durand JM, Buchs N, et al. Human interleukin-17, a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 1999;42:963-970.
4. Teunissen MB, Koomen CW, de Waal Malefyt R, Wierenga EA, Bos JD. Interleukin-17 and interferon-γ synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol. 1998;111:645-649.
5. Ziolkowska M, Koc A, Luszczykiewicz G, et al. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol. 2000;164:2832-2838.
6. Antonysamy MA, Fanslow WC, Fu F, et al. Evidence for a role in IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J Immunol. 1999;162:577-584.
7. Tang JL, Subbotin VM, Antonysamy MA, Trout AB, Rao AS, Thomson AW. Interleukin-17 antagonism inhibits acute but not chronic vascular rejection. Transplantation. 2001;72:348-350.
8. Van Kooten C, Boonstra JG, Pappe ME, et al. Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection. J Am Soc Nephrol. 1998;9:1526-1534.
9. Yao Z, Painter SL, Fanslow WC, et al. Human IL-17: a novel cytokine derived from T cells. J Immunol. 1995;155:5483-5486.
10. Fossiez F, Djossou O, Chomarat P, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med. 1996;183:2411-2415.
11. Aarvak T, Chaubaud M, Miossec P, Natvig JB. IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J Immunol .1999;162:1246-1251.
12. Jovanovic DV, Di Battista JA, Martet-Pelletier J, et al. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-1β and TNF-α, by human macrophages. J Immunol. 1998;160:3513-3521.
13. Attur MG, Patel RN, Abramson SB, Amin AR. Interleukin-17 up-regulation of nitric oxide production in human osteoarthritis cartilage. Arthritis Rheum. 1997;40:1050-1053.
14. Albanesi C, Scarponi C, Cavani A, Federici M, Nasorri F, Girolomoni G. Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes. J Invest Dermatol. 2000;115:81-87.
15. Albanesi C, Cavani A, and Girolomoni G. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-γ and TNF-α. J Immunol. 1999;162:494-502.
16. Woltman AM, de Haij S, Boonstra JG, Gobin SJ, Daha MR, van Kooten C. Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells. J Am Soc Nephrol. 2000;11:2044-2055.
17. Laan M, Cui ZH, Hoshino H, et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol. 1999;162:2347-2352.
18. Chabaud M, Lubberts E, Joosten L, van den Berg W, Miossec P. IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Res. 2001;3:168-177.
19. Schwarzenberger P, La Russa V, Miller A, et al. IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J Immunol. 1998;161:6383-6389.
20. Li H, Chen J, Huang A, et al. Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc Natl Acad Sci U S A. 2000;97:773-778.
21. Shi Y, Ullrich SJ, Zhang J, et al. A novel cytokine receptor-ligand pair. J Biol Chem. 2000;275:19167-19176.
22. Lee J, Ho W-H, Maruoka M, et al. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J Biol Chem. 2001;276:1660-1664.
23. Hymowitz SG, Filvaroff EH, Yin J, et al. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J. 2001;20:5332-5341.
24. Starnes T, Robertson MJ, Sledge G, et al. IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J Immunol. 2001;167:4137-4140.
25. Fort MM, Cheung J, Yen D, et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity. 2001;15:985-995.
26. Yao Z, Fanslow WC, Seldin MF, et al. Herpes-virus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity. 1995;3:811-821.
27. Yao Z, Spriggs MK, Derry JM, et al. Molecular characterization of the human interleukin (IL)-17 receptor. Cytokine. 1997;9:794-800.
28. Tian E, Sawyer JR, Largaespada DA, et al. Evi27 encodes a novel membrane protein with homology to the IL17 receptor. Oncogene. 2000;19:2098-2109.
29. Simonet WS, Hughes TM, Nguyen HQ, Trebasky LD, Danilenko DM, Medlock ES. Long-term impaired neutrophil migration in mice overexpressing human interleukin-8. J Clin Invest. 1994;94:1310-1319.
30. Brinster RL, Chen HY, Trumbauer ME, Yagle MK, Palmiter RD. Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs. Proc Natl Acad Sci U S A. 1985;82:4438-4442.
31. Khare SD, Sarosi I, Xia X-Z, et al. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc Natl Acad Sci U S A. 2000;97:3370-3375.
32. Guo J, Stolina M, Bready JV, et al. Stimulatory effects of B7-related protein-1 on cellular and humoral immune responses in mice. J Immunol. 2001;166:5578-5584.
33. Campana D, Behm FG. Immunophenotyping of leukemia. J Immunol Methods. 2000;243:59-75.
34. Bergui L, Tesio L, Schena M, et al. CD5 and CD21 molecules are a functional unit in the cell/substrate adhesion of B-chronic lymphocytic leukemia cells. Eur J Immunol. 1998;18:89-96.
35. Reading C, Estey EH, Huh YO, et al. Expression of unusual immunophenotyping combinations in acute myelogenous leukemia. Blood. 1993;81:3083-3090.
36. Cabezudo E, Matutes E, Ramrattan M, Morilla R, Catovsky D. Analysis of residual disease in chronic lymphocytic leukemia by flow cytometry. Leukemia. 1997;11:1909-1914.
37. Jankovic D, Liu Z, Gause WC. Th-1 and Th-2 cell commitment during infectious disease: asymmetry in divergent pathways. Trends Immunol. 2001;22:450-457.
38. Fossiez F, Banchereau J, Murray R, Van Kooten C, Garrone P, Lebecque S. Interleukin-17. Int Rev Immunol. 1998;16:541-551.
39. Tominaga A, Takaki S, Koyama N, et al. Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin-5) develop eosinophilia and autoantibody production. J Exp Med. 1991;173:429-437.
40. Lee NA, McGarry MP, Larson KA, Horton MA, Kristensen AB, Lee JJ. Expression of IL-5 in thymocytes/T cells leads to development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies. J Immunol. 1997;158:1332-1344.
41. Macias MP, Fitzpatrick LA, Brenneise I, McGarry MP, Lee JJ, Lee NA. Expression of IL-5 alters bone metabolism and induces ossification of the spleen in transgenic mice. J Clin Invest. 2001;107:949-959.
42. Weltman JK, Karim AS. IL-5: biology and potential therapeutic applications. Expert Opin Investig Drugs. 2000;9:491-496.
43. Foster PS, Mould AW, Yang M, et al. Elemental signals regulating eosinophil accumulation in the lung. Immunol Rev. 2001;179:173-181.
44. Metcalf D. Cellular hematopolesis in the twentieth century. Semin Hematol. 1999;36(4 suppl 7):5-12.
45. Souza L. CSF in vivo: effects on hematopoiesis. Int J Cell Cloning. 1990;8(suppl 1):227-228.
46. De Koning JP, Touw IP. Advances in understanding the biology and function of the G-CSF receptor. Curr Opin Hematol. 1996;3:180-184.
47. Taniguchi T, Minami Y. The IL-2/IL-2 receptor system: a current overview. Cell. 1993;73:5-8.
48. Waldmann TA. The interleukin-2 receptor. J Biol Chem. 1991;266:2681-2684.
49. Heinzel FP, Rerko RM, Hatam F, Locksley RM. IL-2 is necessary for the progression of leishmaniasis in susceptible murine hosts. J Immunol. 1993;150:3924-3931.
50. Kundig TM, Schorle H, Bachmann MF, Hengartner H, Zinkernagel RM, Horak I. Immune responses in interleukin-2-deficient mice. Science. 1993;262:1059-1061.
51. DeFranco AL. B-lymphocyte activation. In: Paul WE, ed. Fundamental Immunology. Philadelphia, PA: Lippincott-Raven; 1999:225-261.
52. Callard RE. Cytokine regulation of B-cell growth and differentiation. Br Med Bull. 1989;45:371-388.
53. Paul WE, Mizuguchi J, Brown M, et al. Regulation of B-lymphocyte activation, proliferation, and immunoglobulin secretion. Cell Immunol. 1986;99:7-13.
54. De Vries JE, Yssel H. Modulation of the human IgE response. Eur Respir J Suppl. 1996;22:58s-62s.
55. Haferlach T, Winkemann M, Loffler H, et al. The abnormal eosinophils are part of the leukemic cell population in acute myelomonocytic leukemia with abnormal eosinophils (AML M4Eo) and carry the pericentric inversion 16: a combination of May-Grunwald-Giemsa staining and fluorescence in situ hybridization. Blood. 1996;87:2459-2463.
56. Hamelmann E, Gelfand EW. IL-5 induced airway eosinophilia-the key to asthma? Immunol Rev. 2001;179:182-191.
57. Matutes E, Kwasi O-A, Morilla R, et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia. 1994;8:1640-1645.
58. Belov L, de la Vega O, dos Remedios CG, Mulligan SP, Christopherson RI. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray. Cancer Res. 2001;61:4483-4489.
59. Pan G, French D, Mao W, et al. Forced expression of murine IL-17E induces growth retardation, jaundice, a Th2-biased response, and multiorgan inflammation in mice. J Immunol. 2001;167:6559-6567.